Billionaire Stanley Druckenmiller Bought Amazon and Alphabet in Q2. But His Single Biggest Holding Is Neither of Them -- and It's Not Nvidia Either.
Natera's growth, expanding role in cancer care, and growing diagnostic data platform help explain why Druckenmiller has made it a major portfolio holding, despite valuation and regulatory risks.
Overview
When you look at Stanley Druckenmiller's latest 13F, the headline names are familiar. He added Amazon and Alphabet again. That fits the narrative most people expect from a billionaire macro investor. What surprised me was that his single biggest holding was neither of those giants nor Nvidia. It was a genetic testing company called Natera (NASDAQ: NTRA).
That tells me something important. When a guy with Druckenmiller's track record makes a company almost one-fifth of his portfolio, I pay attention to what that business does and why it might be worth that kind of conviction. So instead of asking why he owns more Amazon, I find myself asking why he is willing to let a mid-cap diagnostics stock sit at the top of the stack.
Details
Natera is not a household consumer brand. It is a molecular diagnostics company focused on cell-free DNA testing. In plain language, it analyzes tiny fragments of DNA circulating in blood to answer questions about pregnancy, cancer, and organ health.
Source
Originally published at www.fool.com.